Clinical Trial Update: Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sirolimus (rapamycin) for cervico-facial lymphatic malformations in pediatric patients; currently recruiting at University Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Malformation

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: University Hospital, Lille | Conditions: Lymphatic Malformation, Pediatric | Phase 2 | Status: RECRUITING